These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 17682532)
1. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens]. Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI Mikrobiol Z; 2007; 69(3):57-62. PubMed ID: 17682532 [TBL] [Abstract][Full Text] [Related]
2. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use]. Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. Fan SR; Liu XP; Li JW J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710 [TBL] [Abstract][Full Text] [Related]
4. Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women. Verghese S; Padmaja P; Asha M; Elizabeth SJ; Anitha A; Kundavi KM; Jayanthi N; Varma T Indian J Pathol Microbiol; 2001 Jul; 44(3):313-4. PubMed ID: 12024920 [TBL] [Abstract][Full Text] [Related]
5. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women. Ozcan SK; Budak F; Yucesoy G; Susever S; Willke A APMIS; 2006 Feb; 114(2):139-45. PubMed ID: 16519751 [TBL] [Abstract][Full Text] [Related]
6. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan. Abu-Elteen KH Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399 [TBL] [Abstract][Full Text] [Related]
7. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012. Liu XP; Fan SR; Peng YT; Zhang HP J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725 [TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. Choukri F; Benderdouche M; Sednaoui P J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913 [TBL] [Abstract][Full Text] [Related]
9. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents]. García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126 [TBL] [Abstract][Full Text] [Related]
10. Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007. Asticcioli S; Sacco L; Daturi R; Matti C; Nucleo E; Zara F; Pagani L New Microbiol; 2009 Apr; 32(2):199-204. PubMed ID: 19579700 [TBL] [Abstract][Full Text] [Related]
11. [Vulvovaginal candidiasis and sensitivity of pathogens to antimycotics]. Sojáková M; Liptajová D; Simoncicová M; Borovský M; Subík J Ceska Gynekol; 2003 Jan; 68(1):24-9. PubMed ID: 12708111 [TBL] [Abstract][Full Text] [Related]
12. Vulvovaginal candidiasis in a Flemish patient population. De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555 [TBL] [Abstract][Full Text] [Related]
13. Characterisation of yeasts implicated in vulvovaginal candidosis in Irish women. al-Rawi N; Kavanagh K Br J Biomed Sci; 1999; 56(2):99-104. PubMed ID: 10695049 [TBL] [Abstract][Full Text] [Related]
15. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data. Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802 [TBL] [Abstract][Full Text] [Related]
16. [Diagnostic and clinical characteristics of mycotic vaginitis caused by Candida glabrata (Torulopsis glabrata)]. Pawlik B; Liber Z; Warzyńska R Med Dosw Mikrobiol; 1989; 41(3-4):206-14. PubMed ID: 2701236 [TBL] [Abstract][Full Text] [Related]
17. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana. Adjapong G; Hale M; Garrill A Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in Singapore. Kwok YK; Tay YK; Goh CL; Kamarudin A; Koh MT; Seow CS Int J Dermatol; 1998 Feb; 37(2):145-9. PubMed ID: 9542677 [TBL] [Abstract][Full Text] [Related]
19. Soaps and germicides as adjunct topical antimycotic agents on candida species implicated in vulvovaginal candidasis. Ogunshe AA; Omotoso OA; Akindele TM East Afr J Public Health; 2011 Jun; 8(2):112-8. PubMed ID: 22066296 [TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis. Liu XP; Fan SR; Bai FY; Li J; Liao QP Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]